Skip to main content
OpenTrials

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

467 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Active, Not Recruiting

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant

NCT03924401

Conditions
Anemia, Anemia, Aplastic, Anemia, Hemolytic, +19 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Nemours/Alfred I. DuPont Hospital for Children Wilmington, Delaware, United States
  • Childrens Healthcare of Atlanta Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

NCT03842696

Conditions
Acute Leukemia in Remission, Blast Crisis, Bone Marrow Diseases, +37 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic Transplant

NCT05186857

Conditions
Graft vs Host Disease, Graft-Versus-Host Disease, Immune System Diseases
Locations
  • Hospital Marqués de Valdecillas, Santander Santander, Cantabria, Spain
  • Hospital Universitario Reina Sofía Córdoba, Spain
  • Hospital Virgen de las Nieves de Granada Granada, Spain
  • Hospital del Niño Jesús, Madrid Madrid, Spain
View Trial Details
Active, Not Recruiting

Optimizing PTCy Dose and Timing

NCT03983850

Conditions
Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +5 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Active, Not Recruiting

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

NCT03229200

Conditions
Graft vs Host Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Providence Health System - Southern California d/b/a Roy and Patricia Disney Family Cancer Center, The Roy & Patricia Disney Family Cancer Center Burbank, California, United States
  • City Of Hope National Medical Center Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • University of California Los Angeles (UCLA) Los Angeles, California, United States
View all 98 locations
View Trial Details

Related conditions